canadian pharmacy cytotec
Testing facility opening
– Power being upgraded to support operations
February 25, 2019, Coconut Creek, FL Global Consortium, Inc., (OTCPINK: GCGX) continues to expand on America’s first “Cannabis Mall”.
Global Consortium through an Amendment filed with the City can add a testing facility to the Cannabis Mall. Testing is an integral part of the cannabis business. All products must go through rigorous testing before it is allowed to be sold in the state. The testing lab will service outside cannabis vendors as well as all products manufactured within the Cannabis Mall.
The Cannabis Mall is in the process of going through a power upgrade. In order to house all the machinery needed to operate the various licenses, the building needs more power. The process was started a while back and the final phase of connecting the power into the building is expected to be completed within the next 6-8 weeks.
Global Consortium, Inc., is building America’s first Cannabis Mall, which when completed will house Manufacturing, Distribution, Delivery, Retail, Testing, and Cultivation all under one 64,000 square foot building. The Mall will house the largest Manufacturing facility of THC and CBD Distillate and Edibles believed to be operational in the United States.
Global Consortium, Inc., in compliance with SEC regulations, may in the future use social media outlets like Facebook or Twitter and its own website to announce key information in compliance with Reg. FD.
This news release contains “forward-looking statements” as that term is defined in Section 27(a) of the United States Securities Act of 1933, as amended and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, estimates of services and equipment markets, the release of corporate apps, growth of the platform, target markets, product releases, product demand and, business strategy. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also consider that any investment in securities is at risk.
Details of the Company’s business, finances, appointments, and agreements can be found as part of the Company’s continuous public disclosure on otcmarkets.com.
For additional information about this release please contact: